This is a working overview of HPLC, written for readers who want more than a one-paragraph summary but less than a textbook.
Reviewed 2025-11-25. Anything still debated is marked as such rather than presented as settled.
Reconstitution introduces new risks because the peptide contacts solvent, air, and container surfaces. The chosen solvent should match the peptide's solubility profile, and buffer salts, pH, and ionic strength can affect dissolution and subsequent stability. Gentle mixing is preferred over vigorous vortexing, which can create interfaces and shear. If the solution is not clear, the cause may be incomplete dissolution, aggregation, or insoluble counter-ions rather than a simple concentration problem. Filtration is sometimes used, but filters can adsorb peptides and alter measured concentration.
Cold-chain practice relies on documented temperature ranges, calibrated monitoring, and minimized excursions. Shipments may use insulated boxes, phase-change materials, or dry ice, with data loggers to record conditions. Upon receipt, the recipient should verify the logger trace and place items into long-term storage promptly. Repeated warming and cooling during transfers can be more harmful than a single controlled excursion. For solutions, dividing material into single-use aliquots reduces the number of thawing and refreezing events and limits repeated opening of the same container.
Handling begins before a peptide arrives at the bench. Containers should be inspected for cracks, loose caps, or visible moisture, and labels should record identity, lot, and receipt date. Lyophilized material is often allowed to equilibrate to room temperature before opening to prevent condensation on the powder. Gloves and a clean workspace reduce contamination and static-related loss. Once opened, the vial may be purged with inert gas and resealed if the peptide is sensitive to oxygen or humidity. These steps are procedural safeguards rather than guarantees of stability.
Cold-chain shipping uses insulated containers, phase-change packs, and temperature indicators. Dry ice maintains -70 °C or lower but requires venting to avoid pressure buildup. Gel packs provide 2-8 °C for shorter transit. Upon arrival, recipients should record temperature indicators and transfer vials promptly to storage. Deviations from specified conditions should be documented and may require analytical re-check. The effect of a brief temperature excursion is peptide-specific and not always predictable from general rules.
Handling begins with receipt and inspection. Vials should be checked for damage, label integrity, and temperature history. Lyophilized peptides should be allowed to equilibrate to room temperature before opening to prevent condensation. Solutions should be prepared in a clean, calibrated environment using appropriate solvents. Personal protective equipment and containment reduce exposure and contamination. Documentation of lot number, date, and storage location supports traceability. The goal is to limit repeated temperature changes, moisture exposure, and microbial contamination.
| Property | Value | Notes |
|---|---|---|
| Container material | Glass or polypropylene | Low-binding options reduce peptide adsorption |
| Typical shipping condition | Dry ice or gel packs | Choice depends on required temperature range |
| Light protection | Amber vial or foil wrap | Reduces photodegradation of sensitive residues |
| Reconstitution solvent | Water, buffer, or organic co-solvent | Depends on peptide solubility and assay requirements |
| Temperature monitoring | Data logger or indicator | Documents excursions during transport and storage |
Temperature logs and cold-chain documentation help identify excursions that may compromise a batch. Automated freezers, desiccant packs, and sealed containers limit moisture and frost accumulation. Aliquoting small portions before freezing reduces the number of times the main stock changes temperature. Labels should include peptide name, lot, concentration if known, solvent, and date prepared. Periodic analytical verification by high-performance liquid chromatography or mass spectrometry can detect degradation, truncation, or sequence errors that visual inspection cannot reveal.
Practical handling begins with an inventory record that links each vial to a lot number, synthesis date, and purity certificate. Before opening a container, allow it to equilibrate to room temperature to prevent condensation on the powder. Weighing or transferring should occur in a low-humidity environment using tools that minimize static and adsorption. Hygroscopic peptides may gain water quickly, changing mass and concentration estimates. Recording the container's initial mass and any visible changes supports later reconciliation of material.
Quality control links handling to measurable identity and purity. Reverse-phase high-performance liquid chromatography can separate peptide variants and reveal impurities. Mass spectrometry confirms molecular mass and can detect truncations or modifications. These methods are often paired with ultraviolet absorbance or amino acid analysis for concentration. Documentation of instrument settings, column type, and reference standards supports reproducibility. For research materials, acceptance criteria depend on the intended application, and no universal purity threshold applies to all peptides.
Handling begins when a peptide container is opened. Hygroscopic solids can absorb atmospheric water rapidly, so bench work should be brief and containers resealed with fresh desiccant. Weighing or transferring should occur in a low-humidity environment where possible. Static electricity may cause fine powders to cling to surfaces, leading to inaccurate mass measurements. Tools such as antistatic devices or grounded workstations reduce that problem. Good laboratory practice also includes labeling date, lot, and storage condition after each opening.
Reconstitution introduces new variables. The solvent should match the peptide's solubility profile, and water or buffer quality matters because trace metals and microbes can alter results. Adding solvent gently down the vial wall minimizes foaming, which can denature some sequences. Mixing by gentle inversion or swirling is usually preferred over vigorous vortexing. If a peptide does not dissolve readily, adjusting pH or using a small amount of organic co-solvent may help, but such steps can also affect stability and should be documented.
Advising, diagnosing, interpreting, and treating patients Advising health and social care professionals in the diagnosis and treatment of patients Researching the science, technology, and practise used in healthcare to innovate and improve services Designing, building, and operating technology for diagnosing and treating patients Ensuring the safety and reliability of tests and equipment used in healthcare Trainee clinical scientist posts are advertised nationally, usually between November and February on the Clinical scientists recruitment webpages where application forms may be obtained and electronic submission of applications can be made. These posts are for the approved pre-registration training programme, designed to prepare entrants for higher professional qualifications, further clinical training and eventual Consultant responsibility. Clinical scientist training involves enrolment of graduates (first or second class honours degree or better is essential due to the high competition for limited training places) into an intensive three-year training scheme leading to certification and eventual registration before starting the higher career structure.
== Medical uses == CPA is used as a progestin and antiandrogen in hormonal birth control and in the treatment of androgen-dependent conditions. Specifically, CPA is used in combined birth control pills, in the treatment of androgen-dependent skin and hair conditions such as acne, seborrhea, excessive hair growth, and scalp hair loss, high androgen levels, in transgender hormone therapy, to treat prostate cancer, to reduce sex drive in sex offenders or men with paraphilias or hypersexuality, to treat early puberty, and for other uses. Treatment dosages range from 2mg or less, to 100mg or more daily. In the United States, where CPA is not available, other medications with antiandrogenic effects are used to treat androgen-dependent conditions instead. Examples of such medications include gonadotropin-releasing hormone modulators (GnRH modulators) like leuprorelin and degarelix, nonsteroidal antiandrogens like flutamide and bicalutamide, the diuretic and steroidal antiandrogen spironolactone, the progestin medroxyprogesterone acetate, and the 5α-reductase inhibitors finasteride and dutasteride. The steroidal antiandrogen and progestin chlormadinone acetate is used as an alternative to CPA in Japan, South Korea, and a few other countries. In 2020, the European Medicine Agency issued a warning that high doses of cyproterone acetate (25mg daily or more) may contribute to risk of meningioma, and recommended physicians use alternative treatment for most indications (or the minimum effective dose where no alternatives were available) with the exception of prostate carcinoma.
Most important to disease management is exclusion because D. dadantii can move through vegetatively propagated tissues asymptomatically. Therefore, it is important to have certified disease-free stock. Some promising biological control research is being done for orchid species. D. dadantii has been studied in commercially valuable Phalaenopsis orchids. Soft rot diseases caused by Dickeya spp is one of the most devastating diseases in orchid production. Orchid growers have used environmental controls to provide the optimum growth conditions for the plants while minimizing the cultivation of the pathogens. Proper control of humidity and air movement combined with clean, high quality water, in a temperature and light regulated facility are the most commonly employed methods for disease prevention. Other biological controls of D. dadantii include symbiotic fungi known as mycorrhiza and possibly transgenic proteins. Transfer of sweet pepper genes coding for ferredoxin like protein and defensin was shown to reduce D. dadantii disease in Phalaenopsis orchids under cultivation.
On March 2, 2026, Hegseth stated that joint U.S.-Israeli military operations against Iran were a response to prolonged Iranian targeting of American interests. He characterized the actions as an effort to conclude an existing conflict, stating, "We didn't start this war but under President Trump we're finishing it." He noted the death of Supreme Leader Ali Khamenei during the strikes, remarking, "This is not a so-called regime change war, but the regime sure did change". He stated that the primary goals were to "destroy the missile threats, destroy the navy," and ensure there are "no nukes". During the briefing, he issued a direct warning to adversaries: "If you kill or threaten Americans anywhere in the world... we will hunt you down, and we will kill you". Hegseth stated on March 4, 2026, that the Pentagon was "investigating" reports of a deadly airstrike on the Shajareh Tayyebeh girls' school in Minab, Iran, while maintaining that the U.S. military "never targets civilian sites." Evidence indicated that it was the U.S. which most likely bombed the school. On March 10, 2026, Hegseth accused Iran of firing missiles from schools and hospitals and endangering civilians. He also said that Iran is "badly losing" on day 10 of the war.
The Morgan State University Choir has performed for audiences throughout the United States and internationally. Robert Shaw has directed them, together with the Orchestra of St. Lukes and Jessye Norman and others in Carnegie Hall's One Hundredth Birthday Tribute to Marian Anderson. In the 1996-1997 season, the "Silver Anniversary" concert was broadcast throughout the state of Maryland. The concert won an Emmy Award for Maryland Public Television. During 2011-2012 academic years, the choir had several prominent performances. Since 2017, the Morgan State University choir has toured Cuba, Spain, Portugal, Austria, Slovakia, Germany, England, Scotland, Wales, Peru, Ecuador, and the Galapagos Islands. In December 2021, the choir sang a concert in Hawaii, to commemorate the eightieth anniversary of the bombing of Pearl Harbor.
Sources: en.wikipedia.org
== History == More than 50 years ago, MSI was introduced using secondary ion mass spectrometry (SIMS) to study semiconductor surfaces by Castaing and Slodzian. However, it was the pioneering work of Richard Caprioli and colleagues in the late 1990s, demonstrating how matrix-assisted laser desorption/ionization (MALDI) could be applied to visualize large biomolecules (as proteins and lipids) in cells and tissue to reveal the function of these molecules and how function is changed by diseases like cancer, which led to the widespread use of MSI. Nowadays, different ionization techniques have been used, including SIMS, MALDI and desorption electrospray ionization (DESI), as well as other technologies. Still, MALDI is the current dominant technology with regard to clinical and biological applications of MSI.
=== Earliest forms of cooling === The seasonal harvesting of snow and ice is an ancient practice estimated to have begun earlier than 1000 BC. A Chinese collection of lyrics from this time period known as the Shijing, describes religious ceremonies for filling and emptying ice cellars. However, little is known about the construction of these ice cellars or the purpose of the ice. Tang dynasty (618 AD) used saltpetre scraped from walls to produce ice in summer. The next ancient society to record the harvesting of ice may have been the Jews in the book of Proverbs, which reads, "As the cold of snow in the time of harvest, so is a faithful messenger to them who sent him." Historians have interpreted this to mean that the Jews used ice to cool beverages rather than to preserve food. Other ancient cultures such as the Greeks and the Romans dug large snow pits insulated with grass, chaff, or branches of trees as cold storage. Like the Jews, the Greeks and Romans did not use ice and snow to preserve food, but primarily as a means to cool beverages. Egyptians cooled water by evaporation in shallow earthen jars on the roofs of their houses at night. The ancient people of India used this same concept to produce ice. The Persians stored ice in a pit called a Yakhchal and may have been the first group of people to use cold storage to preserve food. In the Australian outback before a reliable electricity supply was available many farmers used a Coolgardie safe, consisting of a box frame with hessian (burlap) sides soaked in water.
=== Cochlear implants === NASA engineer Adam Kissiah started working in the mid-1970s on what became the cochlear implant, a surgically implanted device that allows people suffering from certain kinds of hearing loss, and who receive little or no benefit from traditional hearing aids. Inspired by his own hearing problems, Kissiah, an electronics instrumentation engineer at NASA, spent 3 years of lunches and evenings in Kennedy Space Center's technical library, studying how engineering principles could affect the inner ear. In 1977, NASA assisted Kissiah in obtaining a patent for the cochlear implant.
9e Compagnie de Commandement et de Transmissions (9e CCT) - Command and Signals Company in Poitiers with VAB Régiment d'Infanterie-Chars de Marine (RICM) - Armoured Marine Infantry Regiment (light cavalry) in Poitiers with AMX 10 RC and ERC 90 1er Régiment d'Infanterie de Marine (1er RIMa) - Armoured Marine Infantry Regiment (light cavalry) in Angoulême with AMX 10 RC and ERC 90 2e Régiment d'Infanterie de Marine (2e RIMa) - Marine Infantry Regiment in Le Mans with VBCI 3e Régiment d'Infanterie de Marine (3e RIMa) - Marine Infantry Regiment in Vannes with VAB 126e Régiment d'Infanterie (126e RI) - Infantry Regiment in Brive-la-Gaillarde with VAB (will be the first unit to receive the new VBMR Griffon in 2018) 11e Régiment d'Artillerie de Marine (11e RAMa) - Marine Artillery Regiment in Saint-Aubin-du-Cormier with TRF1 howitzers, CAESAR self-propelled howitzers and RTF1 mortars 6e Régiment du Génie (6e RG) - Engineer Regiment in Angers
ribonuclease (RNase) Any of a class of nuclease enzymes which catalyze the hydrolytic cleavage of phosphodiester bonds in RNA molecules, thus severing polymeric strands of ribonucleotides into smaller components. Compare deoxyribonuclease.
Sources: en.wikipedia.org
Allow the sealed vial to reach room temperature before opening to reduce condensation. Use a suitable solvent and gentle mixing rather than vigorous agitation. Follow the supplier's solubility information when available.
Aliquots limit repeated thawing and refreezing and repeated vial opening, both of which can promote degradation. They also reduce the chance of contaminating an entire batch. Single-use portions should be labeled with identity, concentration, solvent, and date.
Inspect the package for damage and confirm that temperature indicators or data loggers stayed within the specified range. Check the vial condition and labeling before placing it into storage. Record any excursion or discrepancy for the supplier or quality system.
No. Allowing the sealed vial to equilibrate to room temperature reduces condensation on the powder. Condensation can introduce moisture and promote degradation. Equilibration usually takes 15 to 30 minutes depending on vial size.